Isis Pharmaceuticals, Inc.
|
 | ||||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: Another need for KyroOK. But who is going to pay for the evidence based studies so mipo will be covered by an insurance program, Affordable Health Care or your favorite private. Animal models of atherosclerosis respond to everything. They are lipid rich and don't have the fibrosclerosis. Bring on mipo 2.5 oral and we can talk.
|
|||||||||||||||||||
|
|
return to message board, top of board |
